# Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment

> **NCT02098941** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 2500 (estimated)

## Conditions studied

- Epilepsy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02098941
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2014-03-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02098941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02098941, "Evaluate Retention Rate of Topiramate, Levetiracetam and Oxcarbazepine in a Long-term Epilepsy Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02098941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*